CBLL earnings date and last-quarter result: next report 2026-08-10, last quarter miss, P/E -10.32. Updated 2026-07-23.
CeriBell (CBLL) Research Hub
CeriBell (CBLL) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 27.03 USD (-0.37%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.32, market cap 0.65B. This hub links to the full technical, earnings and options research available for CBLL.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 27.03 USD (-0.37%) |
| 52-week range | 16.1 USD – 28.11 USD |
| Trend regime | Range |
| 14-day RSI | 61.1 (Bullish) |
| Trailing P/E | -10.32 |
| Market cap | 0.65B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for CBLL
Covered Call on CBLL: how it works, illustrative setup around the real 27.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CBLL: how it works, illustrative setup around the real 27.03 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CBLL: how it works, illustrative setup around the real 27.03 USD price, max profit/loss, breakeven and when to use it. Educational.
CBLL technical analysis: range, last 27.03 USD, RSI 61.1, 52w range 16.1 USD–28.11 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CBLL in?
CeriBell (CBLL) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is CBLL in an uptrend or downtrend?
As of 2026-10-26, CBLL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CBLL's trailing P/E ratio?
CBLL's trailing P/E is -10.32, with a market cap of 0.65B. See the earnings research page for full valuation detail.
When does CBLL next report earnings?
CBLL is next scheduled to report earnings on 2026-08-10.